Company Overview

Imactiv-3D mission is to assess the efficacy of a molecule of interest by using innovative imaging and quantification tools, and by implementing powerful image processing algorithms on relevant 3D models.

The main challenge of the pharmaceutical industry today is to improve the predictivity of preclinical research. As the success rate of a drug candidate is low, and as drug development is long and costly, we need to address these issues by making research more effective. Imactiv-3D is a fee-for-services company born from the meeting between biology, imaging and image processing experts.

By working together, we have developed 3D imaging procedures to explore biological samples and image analysis algorithms to automatize and strengthen characterization and quantification on innovative 3D models. This complementary expertise along with our R&D service allow our customers to enhance their preclinical data as they can assess the efficacy of their compound or model with better biological relevance and reliability. See our services

Our Expertise

Sample Preparation

Get your samples ready for high quality imaging

Optical clearing
Labelling
3D Immuno-fluorescence in toto

Learn More

Imaging

Our know-how to get the best out of biological samples

Large range of microscopes
Imaging strategy
Wide variety of biological samples

Learn More

Biological Models

Innovative models to better mimic the in vivo

2D & 3D cell culture
Proliferation assays
3D models analysis

Learn More

Image Processing

Fast, reliable and tailor-made image analysis

Pre-processing
Quantification
Visualization

Learn More

Servier has found through this collaboration, an highly experienced partner. Imactiv-3D is a dynamic team, with a young, motivated and reactive crew. Imactiv-3D has pushed the limits of whole heart imaging with its breakthrough technology.

Patricia Sansilvestri-Morel & Stefano Chimenti

Cardiovascular Research, Servier

Imactiv-3D were very receptive to our requests to image the ability of small molecules to protect the heart of mice from the damage of ischemia-reperfusion. We were very satisfied and impressed by their results that go far beyond those obtained with the conventional approaches in terms of information and quantification and will reduce the number of animals.

Catherine Brenner-Jan

INSERM U1180-LabEx LERMIT

We were impressed by the quality, accuracy and robustness of the data Imactiv-3D could provide in a short time. Their approach, combining state of the art image analysis platform with a deep knowledge of image acquisition, segmentation and quantification, allowed us to open a completely new perspective in live cell quantification of virus replication.

Franck Gallardo

CEO NeoVirTech SAS

Our partnership established in Toulouse in 2015 with Imactiv-3D has provided us an undeniable expertise that has strengthened the service offer of our company. Imactiv-3D team has always been listening to our needs and has been able to adapt its tools to our biological models. Our work together is all the easier as their team is dynamic, reactive and shares the same human values as we do.